Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
A33 ANTIBODY COMPOSITIONS AND METHODS OF USING THE SAME IN RADIOIMMUNOTHERAPY
Document Type and Number:
WIPO Patent Application WO/2019/060750
Kind Code:
A3
Abstract:
The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to and neutralize the activity of A33 protein. The antibodies of the present technology are useful in methods for detecting and treating an A33 -positive cancer in a subject in need thereof.

Inventors:
WU ZHIHAO (US)
XU HONG (US)
CHEUNG NAI-KONG (US)
Application Number:
PCT/US2018/052253
Publication Date:
May 16, 2019
Filing Date:
September 21, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MEMORIAL SLOAN KETTERING CANCER CENTER (US)
International Classes:
A61K31/555; A61K39/395; A61K45/00; A61K47/54; A61K51/04; A61P35/00
Domestic Patent References:
WO2016130539A22016-08-18
WO2016164308A12016-10-13
WO2016054005A12016-04-07
Foreign References:
US6307026B12001-10-23
US20020062009A12002-05-23
Other References:
KING ET AL.: "Preparation and Precinical Evaluation of Humanised A33 Immunoconjugates for Radioimmunotherapy", BRITISH JOURNAL OF CANCER, vol. 72, no. 6, 1 December 1995 (1995-12-01), pages 1364 - 1372, XP002911796
Attorney, Agent or Firm:
EWING, James, F. et al. (US)
Download PDF: